RxDoctor Payments DataLook up a doctor →

Nilay Desai, MD

Endocrinology, Diabetes & Metabolism · Rocky Mount, NCNPI 1336157122

Payments from drug & device makers

$405,974in general payments, 2019–2025

Across 525 payments — averaging $773.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$171K
  • Lilly USA, LLC$102K
  • Boehringer Ingelheim$54K
  • Sanofi US Services Inc.$45K
  • Amarin Pharma, Inc.$21K
  • Abbott$6K
  • plus $7K from 13 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$405,974 in reported general payments places this provider in the 90th percentile of 232 endocrinology, diabetes & metabolism providers in North Carolina.

See all endocrinology, diabetes & metabolism providers in North Carolina

Medicare billing

Part B allowed, 2024
$273,961
Medicare patients
753
Services billed
7,935

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other endocrinology, diabetes & metabolism in Rocky Mount

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →